385 related articles for article (PubMed ID: 25006128)
1. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.
Chen WL; Wang JH; Zhao AH; Xu X; Wang YH; Chen TL; Li JM; Mi JQ; Zhu YM; Liu YF; Wang YY; Jin J; Huang H; Wu DP; Li Y; Yan XJ; Yan JS; Li JY; Wang S; Huang XJ; Wang BS; Chen Z; Chen SJ; Jia W
Blood; 2014 Sep; 124(10):1645-54. PubMed ID: 25006128
[TBL] [Abstract][Full Text] [Related]
2. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
[TBL] [Abstract][Full Text] [Related]
3. Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis.
Wang Y; Zhang L; Chen WL; Wang JH; Li N; Li JM; Mi JQ; Zhang WN; Li Y; Wu SF; Jin J; Wang YG; Huang H; Chen Z; Chen SJ; Tang H
J Proteome Res; 2013 Oct; 12(10):4393-401. PubMed ID: 23998518
[TBL] [Abstract][Full Text] [Related]
4. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
5. A three-gene signature might predict prognosis in patients with acute myeloid leukemia.
Zhu X; Zhao Q; Su X; Ke J; Yi Y; Yi J; Lin J; Qian J; Deng Z
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436945
[TBL] [Abstract][Full Text] [Related]
6. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
[TBL] [Abstract][Full Text] [Related]
7. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
[TBL] [Abstract][Full Text] [Related]
8. A novel 4-mRNA signature predicts the overall survival in acute myeloid leukemia.
Chen Z; Song J; Wang W; Bai J; Zhang Y; Shi J; Bai J; Zhou Y
Am J Hematol; 2021 Nov; 96(11):1385-1395. PubMed ID: 34339537
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients.
De Clara E; Gourvest M; Ma H; Vergez F; Tosolini M; Dejean S; Demur C; Delabesse E; Recher C; Touriol C; Martelli MP; Falini B; Brousset P; Bousquet M
Haematologica; 2017 Oct; 102(10):1718-1726. PubMed ID: 28679652
[TBL] [Abstract][Full Text] [Related]
10. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
Wang Y; Zhou Q; Ma JJ
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
[TBL] [Abstract][Full Text] [Related]
11. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y
J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
Leuk Lymphoma; 2008 Mar; 49(3):508-16. PubMed ID: 18297528
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients.
Zhou X; Zheng M; Wang Q; Aa J; Cao B; Li J
Int J Hematol; 2020 Jun; 111(6):761-770. PubMed ID: 32056080
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.
Cao HX; Miao CF; Yan L; Tang P; Zhang LR; Sun L
J Transl Med; 2017 Nov; 15(1):235. PubMed ID: 29141648
[TBL] [Abstract][Full Text] [Related]
16. Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.
Zhu XW; Yao DM; Wu DH; Wen XM; Yang J; Guo H; Yang L; Deng ZQ; Zhang YY; Qian W; Lin J; Qian J
Tumour Biol; 2016 Jan; 37(1):491-501. PubMed ID: 26227220
[TBL] [Abstract][Full Text] [Related]
17. Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity.
Grønningsæter IS; Reikvam H; Aasebø E; Bartaula-Brevik S; Tvedt TH; Bruserud Ø; Hatfield KJ
Cells; 2020 May; 9(5):. PubMed ID: 32392896
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia.
Papaioannou D; Nicolet D; Ozer HG; Mrózek K; Volinia S; Fadda P; Carroll AJ; Kohlschmidt J; Kolitz JE; Wang ES; Stone RM; Byrd JC; Garzon R; Bloomfield CD
Mol Cancer Ther; 2019 Aug; 18(8):1451-1459. PubMed ID: 31164409
[TBL] [Abstract][Full Text] [Related]
19. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
[TBL] [Abstract][Full Text] [Related]
20. A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.
Metzeler KH; Maharry K; Kohlschmidt J; Volinia S; Mrózek K; Becker H; Nicolet D; Whitman SP; Mendler JH; Schwind S; Eisfeld AK; Wu YZ; Powell BL; Carter TH; Wetzler M; Kolitz JE; Baer MR; Carroll AJ; Stone RM; Caligiuri MA; Marcucci G; Bloomfield CD
Leukemia; 2013 Oct; 27(10):2023-31. PubMed ID: 23765227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
